HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi
HealthLynked Corp. (OTCQB: HLYK) has filed a non-provisional patent with the USPTO for ARi, an AI-powered personal healthcare assistant. ARi utilizes GPT and LLM technologies to provide personalized medical recommendations based on users' comprehensive health profiles. This innovative tool aims to address the challenge of inaccurate self-diagnosis from internet searches by incorporating patients' medical records for more tailored guidance.
Dr. Michael Dent, CEO of HealthLynked, emphasized that while ARi represents a significant advancement in patient engagement and personalized care, it is designed to supplement, not replace, professional medical consultations. The potential impact of AI in healthcare is substantial, with estimates suggesting it could save the U.S. healthcare system up to $150 billion annually by 2026.
HealthLynked Corp. (OTCQB: HLYK) ha presentato un brevetto non provvisorio presso l'USPTO per ARi, un assistente sanitario personale alimentato dall'IA. ARi utilizza le tecnologie GPT e LLM per fornire raccomandazioni mediche personalizzate basate sui profili sanitari completi degli utenti. Questo strumento innovativo mira a affrontare la sfida delle diagnosi errate effettuate tramite ricerche online incorporando le cartelle cliniche dei pazienti per una guida più su misura.
Il Dott. Michael Dent, CEO di HealthLynked, ha sottolineato che, sebbene ARi rappresenti un notevole progresso nel coinvolgimento dei pazienti e nella cura personalizzata, è progettato per integrare, non sostituire, le consultazioni mediche professionali. L'impatto potenziale dell'IA nella sanità è sostanziale, con stime che suggeriscono potrebbe far risparmiare al sistema sanitario statunitense fino a $150 miliardi all'anno entro il 2026.
HealthLynked Corp. (OTCQB: HLYK) ha presentado una patente no provisionada ante la USPTO para ARi, un asistente personal de salud impulsado por IA. ARi utiliza las tecnologías GPT y LLM para proporcionar recomendaciones médicas personalizadas basadas en los perfiles de salud completos de los usuarios. Esta herramienta innovadora busca abordar el desafío de los autodiagnósticos inexactos a partir de búsquedas en internet, incorporando los registros médicos de los pacientes para ofrecer una guía más específica.
El Dr. Michael Dent, CEO de HealthLynked, enfatizó que, aunque ARi representa un avance significativo en el compromiso del paciente y la atención personalizada, está diseñado para complementar, no reemplazar, las consultas médicas profesionales. El impacto potencial de la IA en la salud es considerable, con estimaciones que sugieren que podría ahorrar al sistema de salud de EE.UU. hasta $150 mil millones anuales para 2026.
HealthLynked Corp. (OTCQB: HLYK)는 USPTO에 ARi에 대한 비임시 특허를 출원했습니다. ARi는 AI 기반의 개인 건강 관리 도우미입니다. ARi는 GPT 및 LLM 기술을 이용하여 사용자들의 종합적인 건강 프로필에 기반한 개인 맞춤형 의료 추천을 제공합니다. 이 혁신적인 도구는 인터넷 검색을 통한 부정확한 자가 진단 문제를 해결하기 위해 환자의 의료 기록을 통합하여 더 맞춤화된 지침을 제공합니다.
HealthLynked의 CEO인 마이클 덴트 박사는 ARi가 환자 참여 및 개인 맞춤형 치료에서 상당한 발전을 나타내지만, 전문 의료 상담을 대체하기 위해 설계되지 않았다고 강조했습니다. AI가 의료 분야에 미치는 잠재적 영향은 상당하며, 2026년까지 미국 의료 시스템에서 연간 $1500억 절약할 수 있다고 추정됩니다.
HealthLynked Corp. (OTCQB: HLYK) a déposé un brevet non provisoire auprès de l'USPTO pour ARi, un assistant de soins de santé personnel alimenté par l'IA. ARi utilise des technologies GPT et LLM pour fournir des recommandations médicales personnalisées basées sur les profils de santé complets des utilisateurs. Cet outil innovant vise à relever le défi du diagnostic personnel inexact à partir de recherches sur Internet en intégrant les dossiers médicaux des patients pour une orientation plus adaptée.
Le Dr Michael Dent, PDG de HealthLynked, a souligné que, bien qu'ARi représente une avancée significative dans l'engagement des patients et les soins personnalisés, il est conçu pour compléter, et non remplacer, les consultations médicales professionnelles. L'impact potentiel de l'IA dans le secteur de la santé est considérable, avec des estimations suggérant qu'elle pourrait permettre au système de santé américain d'économiser jusqu'à $150 milliards par an d'ici 2026.
HealthLynked Corp. (OTCQB: HLYK) hat ein nicht vorläufiges Patent bei der USPTO für ARi eingereicht, einem KI-gestützten persönlichen Gesundheitsassistenten. ARi nutzt GPT- und LLM-Technologien, um personalisierte medizinische Empfehlungen basierend auf den umfassenden Gesundheitsprofilen der Benutzer bereitzustellen. Dieses innovative Tool zielt darauf ab, die Herausforderung ungenauer Selbstdiagnosen durch Internetrecherchen anzugehen, indem es die medizinischen Aufzeichnungen der Patienten für eine maßgeschneiderte Beratung einbezieht.
Dr. Michael Dent, CEO von HealthLynked, betonte, dass ARi zwar einen bedeutenden Fortschritt im Patienteneinbezug und bei der personalisierten Betreuung darstellt, es jedoch dazu gedacht ist, professionelle medizinische Konsultationen zu ergänzen und nicht zu ersetzen. Der potenzielle Einfluss von KI im Gesundheitswesen ist erheblich, wobei Schätzungen darauf hindeuten, dass sie dem Gesundheitssystem der USA bis 2026 jährlich bis zu $150 Milliarden einsparen könnte.
- Filing of non-provisional patent for AI-powered healthcare assistant ARi
- ARi provides personalized medical recommendations based on users' health profiles
- Potential to improve health outcomes through more accurate, tailored healthcare guidance
- Addresses the challenge of inaccurate self-diagnosis from internet searches
- None.
NAPLES, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in connecting patients, doctors, and healthcare data, announced the filing of its non-provisional patent this past week with the United States Patent and Trademark Office (USPTO) for ARi, an innovative artificial intelligence (AI)-powered personal healthcare assistant. This filing follows the company's provisional patent submission one year ago, shortly after the release of groundbreaking Generative Pre-trained Transformers (GPT) and Large Language Models (LLMs) from OpenAI, marking HealthLynked's early entry into the AI healthcare revolution. The non-provisional patent, if granted, provides long-term protection and exclusivity for Ari and HealthLynked.
ARi leverages the latest in GPT and LLM technologies to transform how patients engage with healthcare. Designed to interact with users in the same way a physician might, ARi allows users to create comprehensive health profiles and provides them with personalized medical recommendations based on their medical history. One of ARi's key features is its ability to answer specific medical questions while incorporating patient data to ensure recommendations are relevant and personalized. This personalized recommendation is unique to Ari and HealthLynked. However, ARi always includes disclaimers advising users to seek medical advice from a licensed physician, ensuring that the AI acts as a supportive tool rather than a substitute for professional medical care.
"At HealthLynked, we are committed to empowering patients to take control of their health," said Dr. Michael Dent, CEO of HealthLynked. "ARi is an exciting leap forward in this mission. By integrating AI with patient medical records, we can deliver more accurate healthcare guidance tailored to the individual, significantly improving health outcomes. This is a game-changer in healthcare delivery."
ARi addresses a significant challenge in modern healthcare: the widespread use of the internet for self-diagnosis. Patients often search for symptoms online, which can lead to misleading or inaccurate information due to the lack of personal medical context. ARi overcomes this by accessing the user's healthcare profile and medical records, allowing it to deliver recommendations tailored specifically to the patient's unique health history. This personalized approach helps ensure that users receive more accurate guidance, potentially enabling them to seek appropriate care sooner, reduce unnecessary delays, and alleviate the anxiety that comes with misinformed online searches.
ARi represents a significant advancement in patient engagement and personalized care. However, as with all AI-driven technologies in healthcare, it serves only as a supplement to traditional medical consultations. "AI can offer valuable insights, but it's essential for patients to consult with their physicians to confirm any medical decisions," Dr. Dent emphasized.
The potential for AI to transform healthcare is enormous. A report by Accenture suggests that AI applications could save the U.S. healthcare system up to
For more information about HealthLynked and its AI-driven initiatives, visit www.healthlynked.com.
About HealthLynked Corp.
HealthLynked Corp. is dedicated to transforming healthcare through technology and connectivity. Our platform empowers patients to control their medical information, enabling seamless collaboration between patients and healthcare providers. By centralizing and securing health data, we improve access to critical information, enhancing patient care and communication.
Join us in our journey towards a healthier future. Download the HealthLynked app on Apple or Android devices and take control of your healthcare today. Visit www.healthlynked.com for more information and connect with us on Twitter, Facebook, Instagram, YouTube, and LinkedIn.
Forward-Looking Statements & Risk Factors
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance, or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.
Media and Investor Contact:
Michael Paisan
Director of Investor Relations
HealthLynked Corp.
Email: ir@healthlynked.com
Phone: (800) 928-7144
FAQ
What is ARi and how does it work?
How does ARi differ from typical online symptom searches?
Can ARi replace consultations with a doctor?
What potential impact could AI have on healthcare costs according to the HealthLynked (HLYK) press release?
